Permanent Bar Against Glenmark's Sitagliptin Copies

The Delhi High Court has permanently enjoined Glenmark Pharmaceuticals Ltd from making and selling its generic version of Merck & Co's diabetes therapies Januvia (sitagliptin) and Janumet (sitagliptin/metformin hydrochloride). The Indian firm has been found to have infringed the sitagliptin patent.